TreeFrog Therapeutics
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $82.0Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2025-06-01attributed |
| Founded | 2018 |
| Headquarters | Bordeaux, France |
| Industry | biotech |
| Stage | unknown |
| Website | treefrog.fr |
TreeFrog Therapeutics develops cell therapies from iPS-derived 3D microtissues, with a lead program targeting Parkinson's disease. It serves patients with serious diseases who could benefit from regenerative cell therapy. Its C-Stem encapsulation platform enables billions of cells per batch for commercial-scale manufacturing.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-06-01 | grant | $2.7M | undisclosed |
Detected tech stack
PHP 7.4, Lenis 1.1.13, Yoast SEO 24.9, YouTube, Google Analytics, Google Tag Manager, DoubleClick Floodlight, Contact Form 7 6.0.6, WPML 4.7.3, MySQL, wordpress .
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $82.0M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | treefrog.fr, read 2026-05-08 |
| Description | self-reported | treefrog.fr, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.